SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is seeing intense volatility as investors weigh a proposed seven billion dollar financing round against a reported thirty-nine billion dollars in new orders. The community is sharply divided, with bulls highlighting massive AI infrastructure demand and potential upside, while bears point to dilution concerns and geopolitical risks dragging on the stock.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors react to strong operational metrics from its predictions platform, which is seeing rapid volume growth and helping the company expand into restricted markets. The community remains polarized, with bulls highlighting the platform's long-term growth potential and recent analyst optimism, while bears express frustration over the stock's historical underperformance and lack of active share buybacks from management.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is currently under significant downward pressure as market participants weigh conflicting signals regarding Middle East geopolitical tensions and cooling inflation expectations. The community is actively debating whether current price levels offer a bargain-hunting opportunity or if persistent macroeconomic headwinds will force a deeper technical correction for the precious metal.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed is experiencing significant volatility and intense discussion as traders speculate on a potential short squeeze, fueled by high short interest and anticipation surrounding its role in next-generation AI data center power infrastructure. While some investors remain cautious about long-term fundamental challenges and share dilution, others are closely tracking new product developments and strategic collaborations as key catalysts for a potential price re-rating.

Casey's General Stores, Inc. engages in the provision of management and operation of convenience stores and gasoline stations. It provides self-service gasoline, a wide selection of grocery items, and an array of freshly prepared food items. The firm offers food, beverages, tobacco products, health and beauty aids, automotive products, and other non-food items. The company was founded by Donald F. Lamberti in 1968 and is headquartered in Ankeny, IA.

Casey`s General Stores, Inc.

Casey's General Stores, Inc.

Casey's General Stores is trending as investors digest a strong earnings report featuring a significant EPS beat and raised EBITDA guidance, fueling discussions about its aggressive expansion plans and resilient performance in the convenience retail sector. Community sentiment remains largely bullish, with traders weighing the company's consistent growth against concerns regarding stretched valuations and potential consumer spending fatigue.

Magnite, Inc. provides a technology solution to automate the purchase and sale of digital advertising inventory for buyers and sellers. It features applications and services for digital advertising sellers including websites, mobile applications, and other digital media properties. The company was founded by Frank Addante, Duc Chau, Craig Roah, Julie Mattern and Brian D. Baumgart on April 20, 2007 and is headquartered in New York, NY.

Magnite Inc

Magnite is currently seeing significant social media attention as investors debate its valuation relative to its programmatic growth and the potential for a favorable antitrust ruling against Google. Community discussions are highly focused on the company's Q4 earnings, recent partnership expansions, and the expectation that aggressive share repurchases could provide a floor for the stock price.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently trending due to a combination of persistent undervaluation, massive share buybacks, and ongoing rumors of potential acquisition by major fintech players. The community is actively debating the stock's future, with many bullish investors highlighting its strong cash flow and AI-driven checkout initiatives while others express frustration over the company's sluggish price performance and management's strategic direction.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is experiencing significant momentum and investor interest, driven by the highly anticipated plenary presentation of its ivonescimab clinical data at the upcoming ASCO conference. The community is actively debating the stock's potential as a major oncology disrupter while monitoring for institutional positioning and potential acquisition interest ahead of the company's key regulatory and clinical catalysts.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets, Data Centers, and Treasury and Corporate. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The Treasury and Corporate segment includes the company’s proprietary trading and mining activities, as well as the company’s principal investments and related gains and losses. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is trending as retail investors scrutinize the company's pivot from crypto-focused operations to large-scale AI data center infrastructure at its Helios campus. Community sentiment remains highly polarized, with many traders expressing deep frustration over recent price volatility and perceived leadership shortcomings, while others remain bullish on the long-term potential of the firm's data center capacity and upcoming tenant announcements.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Market participants are intensely focused on the QQQ as it experiences high volatility driven by conflicting geopolitical headlines involving Iran and upcoming CPI data. Community discourse remains divided between those capitalizing on the rapid intraday swings through aggressive scalping and those debating whether the recent price action indicates a structural correction or a temporary shakeout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse technology using proprietary nanosecond pulsed field ablation (nsPFA) energy, today announced plans to participate in the upcoming Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, FL. Pulse Biosciences Management is...

Here's Why Pulse Biosciences, Inc (PLSE) is a Great Momentum Stock to Buy

Does Pulse Biosciences, Inc (PLSE) have what it takes to be a top stock pick for momentum investors? Let's find out.

Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors.

Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors...

ATM Equity Purchases by Pulse Biosciences Co-Chairmen Total Approximately $13.3 Million

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse technology using proprietary nanosecond pulsed field ablation (nsPFA) energy, today announced its Co-Chairmen of the Board, Robert Duggan...

Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse technology using proprietary nanosecond pulsed field ablation (nsPFA) energy, today announced plans to participate in the upcoming BofA...

Pulse Biosciences (PLSE) Upgraded to Buy: What Does It Mean for the Stock?

Pulse Biosciences (PLSE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Pulse Biosciences (NASDAQ:PLSE) Announces Quarterly Earnings Results, Beats Estimates By $0.05 EPS

Pulse Biosciences (NASDAQ:PLSE - Get Free Report) issued its earnings results on Monday. The company reported ($0.27) EPS for the quarter, topping analysts' consensus estimates of ($0.32) by $0.05...

Pulse Biosciences, Inc (PLSE) Reports Q1 Loss, Lags Revenue Estimates

Pulse Biosciences (PLSE) delivered earnings and revenue surprises of +15.63% and -19.80%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of novel nPulse technology using proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced business updates and...

Pulse Biosciences (PLSE) Expected to Announce Quarterly Earnings on Thursday

Pulse Biosciences (NASDAQ:PLSE) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-pulse-biosciences-inc-stock...

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.

PLSEPulse Biosciences Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PLSE News